This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Gair Ford, PhD
Regulatory CMC Director at Astrazeneca

Profile

Gair Ford PhD has over 20 years’ experience in the pharmaceutical industry as process development chemist and is currently a regulatory CMC director. In his current role he oversees the regulatory strategy for a number of projects in clinical development through to marketing submissions. He also sits on the impurities advisory group within AstraZeneca and the AstraZeneca nitrosamines risk management team. Externally to AstraZeneca he is a visiting lecturer at Sheffield University and represents AstraZeneca on the European Federation of Pharmaceutical Industries and Associations (EFPIA) and IQ consortium nitrosamine teams and the EPOC regulatory sub team.

Agenda Sessions

  • Development of a General Position for the Nitrosamines Risk Assessment of Oligonucleotide Products

    10:45